Follow the Dr. Lal Pathlabs stock price and the full insider trade history of the company, a publicly traded company based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Market capitalisation: €317bn. The latest transaction was filed on 25 August 2026 (Disposal). Among the most active insiders: Amit Aggarwal. All data is accessible without an account.
88
Insider Decl.
n/a
Thresholds
€3m
36 ops.
Buy Volume
€8m
52 ops.
Sell Volume
39Σ signal
Buys €3m€8m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,751 of 28,880 companies
59.6
score / 100
Value
32
Quality
87
FCF yld1.5%
Earn yld1.6%
EV/EBITDA37.4x
ROE21%
Gross mgn81%
Net mgn18%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
500 shares@ ₹1,921.000.0003% mcap12.5% of flowEquityMarket SaleSEBI:50cbfd6e3f839705bca3a92324a8879404202946
25 of 88 declarations
Acerca de Dr. Lal Pathlabs
Dr. Lal Pathlabs es una empresa india especializada en servicios de diagnóstico médico. Ofrece una amplia gama de pruebas de laboratorio para pacientes e instituciones sanitarias.